CLINICAL_TRIALS trial_result · 2024-10-04

Clinical Trial Update: The Use of ARA290 for the Treatment of Diabetic Macular Oedema [Phase 2]

Phase 2 trial of the drug ARA-290 for diabetic macular edema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Belfast Health and Social Care Trust | Conditions: Diabetic Macular Oedema | Phase 2 | Status: TERMINATED